This content was created by Everyday Health Media on behalf of an advertiser.
More Information.
Content on this page was created by the Everyday Health Media team and is funded by an advertiser. The content conforms to Everyday Health Media’s editorial standards for accuracy, objectivity, and balance. The advertiser may select the specialty area but does not edit or approve the content.
Pediatric Meningitis
In Febrile Children Presenting to the ED, Watch Out for This Sign
With the goal of reducing unnecessary treatment, researchers investigated whether clinical signs of petechial rash or symptoms such as coughing or vomiting could be used as diagnostic markers to help confirm or rule out sepsis and/or meningitis.
Childhood Vaccination: One Rural State’s Experience
Given the prevalence of vaccine hesitancy and other factors, getting kids to complete their early vaccine series by the age of two is a challenge. But what happens when distance to a provider is thrown into the mix? Do vaccination rates shift dramatically?
In Pediatric Sepsis and Bacterial Meningitis, Procalcitonin Predicts Poor Outcomes
Findings from an Italian study suggest that procalcitonin levels, in combination with clinical features, can help emergency department staff predict poor outcomes for children with sepsis or bacterial meningitis.
In Neonatal Sepsis, When are Empiric Antibiotics Appropriate?
Investigators in Italy recently assessed whether early administration of antibiotics improves survival in preterm infants with late-onset sepsis—and, if so, what factors come into play.
Does This Infant Have a Post-vaccine Adverse Event—or Another Infection?
This retrospective observational study demonstrated that routine blood tests are often ineffective in determining the difference between AEFIs and other infections and that additional research into diagnostics and clinical prediction tools is required.
Late-Onset Meningitis: Incidence and Outcomes in Extremely Preterm Infants
Among the findings from this study was the observation that lumbar puncture is underutilized in extremely preterm infants with possible late-onset meningitis.
Serogroup B Meningococcal Prevention Efforts Vary Globally
Many countries have approved the use of one or both available protein-based vaccines for MenB, but immunization schedule policies and recommendations vary widely, and MenB vaccination coverage and surveillance data for many countries remain limited.
Meningococcal Vaccine Uptake: The Impact of Social Deprivation
A study using data from Northern Ireland found that school absenteeism and low educational attainment are strongly correlated with reduced meningococcal vaccine uptake.
What’s Driving Vaccine Hesitancy in Pediatric Settings?
To combat growing vaccine hesitancy and an increasing proportion of children who are not up to date on recommended vaccinations, these authors recommend that healthcare providers engage in shared decision-making to address individual questions and concerns.
Invasive Meningococcal Disease Remains a Threat in North America
Experts warn of the looming threat of IMD as a result of reduced vaccinations during the COVID-19 pandemic, antibiotic resistance, and low serogroup B immunogenicity.